Evidence map›Paper›PMID 36635459›Full record

ArticleGenes & genomics2023

Genomic insights of Leclercia adecarboxylata strains linked to an outbreak in public hospitals in Mexico.

Edwin Barrios-Villa, Brenda Pacheco-Flores, Patricia Lozano-Zaraín, Rodolfo Del Campo-Ortega, Ivan de Jesús Ascencio-Montiel, Margot González-León, Margarita Camorlinga-Ponce, Francisco Javier Gaytán Cervantes, Carolina González Torres, Emmanuel Aguilar and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Genes & genomics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Resistance phenotype and virulence potential ofMicrobiology (Reading, England) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Edwin Barrios-VillaLaboratorio de Biología Molecular y Genómica de Microorganismos de Interés Clínico y Económico, Departamento de Ciencias Químico Biológicas y Agropecuarias, Universidad de Sonora, Av. Universidad e Irigoyen S/N, col. Eleazar Ortiz, Sonora, 83621, H. Caborca, Mexico.
Brenda Pacheco-FloresPosgrado en Microbiología, Centro de Investigaciones en Ciencias Microbiológicas, Benemérita Universidad Autónoma de Puebla, Av. San Claudio S/N, 72570, Puebla, Mexico.
Patricia Lozano-ZaraínPosgrado en Microbiología, Centro de Investigaciones en Ciencias Microbiológicas, Benemérita Universidad Autónoma de Puebla, Av. San Claudio S/N, 72570, Puebla, Mexico.
Rodolfo Del Campo-OrtegaCoordinación de Evaluación de la Calidad Médica, Instituto Mexicano del Seguro Social, 06720, Mexico City, Mexico.
Ivan de Jesús Ascencio-MontielCoordinación de Vigilancia Epidemiológica, Instituto Mexicano del Seguro Social, 03100, Mexico City, Mexico.
Margot González-LeónDirección de Prestaciones Médicas, Instituto Mexicano del Seguro Social, 06600, Mexico City, Mexico.
Margarita Camorlinga-PonceUnidad de Investigación en Enfermedades Infecciosas y Parasitarias, Instituto Mexicano del Seguro Social, 06720, Mexico City, Mexico.
Francisco Javier Gaytán CervantesLaboratorio de Secuenciación, División de Desarrollo de la Investigación, Centro Médico Nacional "Siglo XXI", Instituto Mexicano del Seguro Social, 06720, Mexico City, Mexico.
Carolina González TorresLaboratorio de Secuenciación, División de Desarrollo de la Investigación, Centro Médico Nacional "Siglo XXI", Instituto Mexicano del Seguro Social, 06720, Mexico City, Mexico.
Emmanuel AguilarDepartamento de Microbiología, Microbiología Médica, Escuela Nacional de Ciencias Biológicas del Instituto Politécnico Nacional (ENCB-IPN), Mexico City, Mexico.
Joaquín González IbarraCoordinación de Investigación en Salud, Centro Médico Nacional "Siglo XXI", Instituto Mexicano del Seguro Social, 06720, Mexico City, Mexico.
Francisco Javier Torres LópezUnidad de Investigación en Enfermedades Infecciosas y Parasitarias, Instituto Mexicano del Seguro Social, 06720, Mexico City, Mexico.
Haydeé Rosas-VargasUnidad de Investigación Médica en Genética Humana, UMAE Hospital de Pediatría, Centro Médico Nacional "Siglo XXI", Instituto Mexicano del Seguro Social (IMSS), 06720, Mexico City, Mexico.
César R González-BonillaUnidad de Investigación Médica en Genética Humana, UMAE Hospital de Pediatría, Centro Médico Nacional "Siglo XXI", Instituto Mexicano del Seguro Social (IMSS), 06720, Mexico City, Mexico.
Rosa Del Carmen Rocha-GraciaPosgrado en Microbiología, Centro de Investigaciones en Ciencias Microbiológicas, Benemérita Universidad Autónoma de Puebla, Av. San Claudio S/N, 72570, Puebla, Mexico. rochagra@yahoo.com.ORCID http://orcid.org/0000-0002-0456-8264

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLeclercia adecarboxylata is a bacteria closely related to Escherichia coli according to its biochemical characteristics and is commonly considered non-pathogenic although a growing number of publications classify it as an emerging pathogen. Fosfomycin resistance is a common trait for L. adecarboxylata encoded by fosA

objectiveTo analyze genomic traits of sixteen L. adecarboxylata strains isolated from blood culture and a bottle of total parenteral nutrition.

methodsTwenty-eight L. adecarboxylata strains isolated from blood culture and a bottle of total parenteral nutrition were identified biochemically with a Vitek ® automated system. The strains were phenotyped by their growth on Eosin Methylene Blue agar or MacConkey agar plates. Additionally, Pulsed field gel electrophoresis (PFGE) was performed to establish the clonal relationship. The genomic DNA of sixteen strains was obtained using a Qubit ® dsDNA HS Assay Kit and sequenced on an Illumina ® MiSeq instrument. Draft genomes were assembled using PROKKA and Rast. Assemblies were submitted to Resfinder and PathogenFinder from the Center for Genomic Epidemiology in order to find resistance genes and pathogenic potential. IslandViewer4 was also used to find Pathogenicity and Phage Islands. For identification of the fosA gene, manual curation and Clustal analysis was performed. A novel FosA variant was identified. Finally, phylogenetic analysis was performed using VAMPhyRE software and Mega X.

resultsIn this paper, we report the genomes of sixteen strains of Leclercia adecarboxylata causing an outbreak associated with parenteral nutrition in public hospitals in Mexico. The genomes were analyzed for genetic determinants of virulence and resistance. A high pathogenic potential (pathogenicity index 0.82) as well as multiple resistance genes including carbapenemics, colistin and efflux pumps were determined. Based on sequence analysis, a new variant of the fosA

conclusionsCommensal strains of L. adecarboxylata may acquire genetic determinants that provide mechanisms of host damage and go unnoticed in clinical diagnosis. L. adecarboxylata can evolve in a variety of ways including the acquisition of resistance and virulence genes representing a therapeutic challenge in patient care.

Indexed as

Enterobacteriaceae InfectionsAgarAnti-Bacterial AgentsDisease OutbreaksEnterobacteriaceaeEscherichia coliGenomicsHospitals, PublicHumansMexicoPhylogenyAgarAnti-Bacterial AgentsAntibiotic resistanceEmerging pathogenLeclercia adecarboxylata

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.